Categories: Research

UCSF School of Pharmacy leads in NIH funding for the 40th straight year

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.

QBI Coronavirus Research Group races toward a cure

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

2020 Mary Anne Koda-Kimble Seed Award for Innovation fuels vital research across the School

The award funds the boldest, riskiest, and most blue-sky ideas.

UCSF features expertise in kidney care and work on artificial kidney

A team of kidney experts talk about kidney disease and share their hopes for the future.

Assemi wins award for work on PharmD experiential education

Mitra Assemi, PharmD, was honored for her research on the hands-on components of pharmacy curricula around the U.S.

Sample medications and detailing visits add to costs, Guglielmo argues

Free samples of medications and “detailing visits” are costly, B. Joseph Guglielmo argues in JAMA.

FDA, academia, and industry join forces to shepherd new therapies to patients

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

Implantable bioartificial kidney achieves preclinical milestone

Scientists implanted a prototype kidney bioreactor in large animals without significant safety concerns.

VR drug discovery makes precision therapy a reality

ChimeraX, virtual reality software developed at the UCSF Resource for Biocomputing, Visualization and Informatics, is now the tool of choice for computational structural biologists in the School of Pharmacy. The Jacobson Lab recently used ChimeraX to find a promising new cure for a drug-resistant...

Pages